Company / Operating Margin
Valion Bio, Inc. Operating Margin History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-701.1%
FY2024
5-year range
-701.1% / -448.1%
FY2022-FY2024
Trend
-27.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -448.1% to -701.1% over the past 2 years.
Based on SEC 10-K filings.
-701.1% in FY2024.
Declined from -448.1% to -701.1% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, operating margin decreased 27.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -10.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -701.1% | -27.8% |
| FY2023 | -548.8% | -22.5% |
| FY2022 | -448.1% | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026